Related Experiment Video
Updated: Jul 15, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Genetic and proteomic characterization of rifaximin resistance in Bifidobacterium infantis BI07
Beatrice Vitali1, Silvia Turroni, Fabrizio Dal Piaz
1Department of Pharmaceutical Sciences, CIRB-center for Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.
Abstract:
Rifaximin resistance in the probiotic strain Bifidobacterium infantis BI07 was studied to assess the use of an antibiotic-probiotic combination for clinical management of intestinal disorders. A rifaximin-resistant mutant was selected and a 129 bp core region of the rpoB gene was sequenced and compared with the respective sequence of the sensitive clone. A miss-sense mutation of codon 513, producing the substitution of Gln with Arg in the protein sequence, was found. The involvement of metabolic changes associated with rifaximin resistance was also investigated by proteomic analysis performed with two-dimensional electrophoresis and mass spectrometry. The principal categories of proteins, whose expression levels varied as a consequence of rifaximin resistance, included chaperonins, regulatory factors and metabolic enzymes. The hypothesis of rifaximin inactivation by bacterial enzymatic activities was excluded, as neither structural modifications nor degradation derivates of the drug moiety was identified using liquid chromatography coupled with tandem mass spectrometry.
Insights
Investigating rifaximin resistance in Bifidobacterium infantis BI07 revealed a specific gene mutation. This finding impacts the use of antibiotic-probiotic combinations for intestinal disorders.
Area of Science:
- Microbiology
- Genetics
- Pharmacology
Background:
- Antibiotic-probiotic combinations are explored for managing intestinal disorders.
- Understanding antibiotic resistance in probiotics like Bifidobacterium infantis is crucial.
Purpose of the Study:
- To investigate rifaximin resistance in Bifidobacterium infantis BI07.
- To assess the implications of this resistance for antibiotic-probiotic therapy.
Main Methods:
- Selection of a rifaximin-resistant mutant of Bifidobacterium infantis BI07.
- Sequencing of the rpoB gene's core region to identify mutations.
- Proteomic analysis using two-dimensional electrophoresis and mass spectrometry to study metabolic changes.
- Liquid chromatography coupled with tandem mass spectrometry to assess drug inactivation.
Main Results:
- A miss-sense mutation in codon 513 of the rpoB gene was identified, substituting Gln with Arg.
- Proteomic analysis indicated altered expression of chaperonins, regulatory factors, and metabolic enzymes in resistant strains.
- No evidence of rifaximin inactivation by bacterial enzymatic activities was found.
Conclusions:
- A specific mutation in the rpoB gene confers rifaximin resistance in Bifidobacterium infantis BI07.
- Metabolic changes accompany rifaximin resistance, affecting protein expression.
- Rifaximin resistance in this probiotic is not due to drug inactivation by bacterial enzymes.
Related Concept Videos
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance